News & Media / Newsroom
Alfasigma Mexico has been selected among more than 700 companies as one of the best 100 to work for in 2021.
The selection was determined by a survey sent to different employees in the Country by a moderating company.
The nomination of the Alfathon finalists took place during the first appointment with the INNOVATION TALKS, the Clubhouse room dedicated to technological innovation and health.
The United Nations marks April 21st as the World Creativity and Innovation Day. For that reason, Alfasigma launches INNOVATION TALKS, a Clubhouse room focused on innovation technologies and health.
v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis.
Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented in DUBAI during the EXPO.
An innovative geo-localization software has being launched to increase knowledge & awareness about the disease.
This year, Alfasigma will be Sponsor of the Vein Week, organized by v-WIN Foundation (Scientific Society in Phlebology). The initiative will take place from April, 5th to 11th and on the occasion, a Geomap Calendar software was developed, showing, within an interactive map, vascular events uploaded to the platform by the organizers themselves, upon approval of v-WIN Foundation.
Cosmo Pharmaceuticals will receive a €4m upfront payment Alfasigma plus double digit royalties.
Lumeblue™ was ecently approved by EMA for the detection of lesions during colonoscopy.
Alfasigma will distribute Lumeblue™ in EU, Switzerland, UK, European Economic Area countries, Russia and Mexico.
[email protected]
+39.051.6489.562
+39.051.6489.884
+39.06.9139.4396
You’re entering Alfasigma global website
I agree